Related Experiment Video
Updated: Jun 1, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Recent trends in pulmonary arterial hypertension
1Department of Pulmonary and Critical Care Medicine, University of Massachusetts, Worcester, MA, USA.
Early diagnosis of pulmonary hypertension (PH) is crucial. Prompt treatment offers improved quality of life and survival, changing the disease
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Pulmonary hypertension (PH) is a severe condition impacting patient quality of life and survival.
- Early diagnosis and treatment are vital for better outcomes.
- Subtle early symptoms necessitate physician awareness and thorough investigation.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension (PAH).
- To emphasize the importance of early recognition and management by pulmonologists and cardiologists.
- To guide management strategies for patients with WHO group 1 pulmonary hypertension.
Main Methods:
- Literature review of the past 30 years using Medline.
- Keywords included primary pulmonary hypertension, pulmonary arterial hypertension, secondary pulmonary hypertension, and pulmonary vascular diseases.
- Focus on WHO group 1 pulmonary hypertension (PAH).
Main Results:
- New therapeutic options can significantly improve quality of life and prolong survival.
- Early detection through thorough investigation is essential for prompt treatment initiation.
- Management requires awareness of PAH pathophysiology, diagnostic workup, and available treatments.
Conclusions:
- Physicians must be aware of subtle early signs of PH for timely diagnosis.
- Appropriate workup can often be performed in well-equipped hospitals.
- Referral to specialized centers is recommended for refractory cases and clinical trial enrollment.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

